In this regard, Lamers et al. have reported the emergence of humoral and cellular immune responses against the targeting domain of autologous carbonic anhydrase IX (CAIX)-redirected CAR-Ts in patients with renal cell carcinoma [50]. The gene discussed is CA9; the disease is renal cell carcinoma.